
RemeGen's Telitacicept Approved for Treatment of Myasthenia Gravis in China
China’s National Medical Products Administration (NMPA) recently approved telitacicept (RemeGen), an investigational agent, for the treatment of adult patients with anti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG) to …